Skip to main content

KC 15 (Potassium Citrate Extended-Release 15 mEq (1620 mg))

Pill with imprint KC 15 is Yellow, Elliptical / Oval and has been identified as Potassium Citrate Extended-Release 15 mEq (1620 mg). It is supplied by Bionpharma Inc..

Potassium citrate is used in the treatment of renal tubular acidosis; nephrolithiasis and belongs to the drug class urinary pH modifiers. Risk cannot be ruled out during pregnancy. Potassium citrate 15 mEq (1620 mg) is not a controlled substance under the Controlled Substances Act (CSA).

Images for KC 15

Potassium Citrate Extended-Release

KC 15
15 mEq (1620 mg)
Elliptical / Oval
Prescription only
Drug Class
Urinary ph modifiers
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Bionpharma Inc.
National Drug Code (NDC)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.